An interventional study of Lipo-abdominoplasty and Abdominoplasty in Skin; Excess, sponsored by Karolinska University Hospital. Withdrawn at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-10.
Sponsored by Karolinska University Hospital · Not applicable, Interventional, and Treatment
Excess skin on the abdomen is a common problem for many individuals after massive weight loss. The surgical procedure of abdominoplasty is intended to remove excess skin and improve the shape of the torso in abdomen, in order to address issues such as skin fold eczema, difficulties finding clothing, and psychosocial issues.
The investigators will conduct a randomized, controlled trial where individuals with excess skin on the abdomen will be randomized to either standard abdominoplasty or abdominoplasty in combination with liposuction. The investigators will examine the rate of complications, and the functional and aesthetical outcomes of the two methods.
1,766 studies on the registry are indexed under Weight Loss; 277 are open to participants now.
Browse Weight Loss studies →Karolinska University Hospital is the lead sponsor of 275 studies on the registry; 54 are open to participants now.
Counted across the registry records on this site, refreshed daily.
This study is open only to individuals who are residents in Sweden and qualify for government-funded, inpatient, non-emergency health care within the Stockholm Region.
Inclusion Criteria:
Exclusion Criteria:
Standard abdominoplasty
Procedure: Abdominoplasty
Abdominoplasty plus liposuction
Procedure: Lipo-abdominoplasty
Abdominoplasty plus liposuction
Abdominoplasty
Number of and type of complications within 30 days
Number of and type of complications occurring within 30 days of surgery
Time frame: 30 days
Average need for analgesia in morphine equivalents
Average need for analgesia in morphine equivalents during post-operative day 1
Time frame: Post-operative day 1
Average score on BodyQ score
Average score on BodyQ score including subscales. BodyQ is developed and owned by Memorial Sloan Kettering Cancer Center. The BODY-Q is composed of 27 independently functioning scales that measure 3 overarching constructs Appearance, Quality of Life and Experience of Care. Scales are translated to a 0-100 score where a lower score means worse outcome.
Time frame: At baseline, at 3 months post-operatively, at 12 months post-operatively
Average score on aesthetic result
Average score on aesthetic result on a 1-10 scale where a lower score means worse outcome.
Time frame: At 12 months post-operatively
Average days until discharge
Average days until discharge post-operatively
Time frame: Days
Plan to share: No
No publications or documents are linked to this record.
This study is withdrawn, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Karolinska University Hospital